Ruihua Dong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ruihua Dong has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
- Shaojie Liu
Department of Clinical Nutrition, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China
12 shared publications - Bo Chen
Fudan University
11 shared publications - Jun Du
Nutrilite Health Institute, Amway (Shanghai) Innovation & Science Co., Ltd., Shanghai 201203, China
6 shared publications Long Zhao
Key Lab of Public Health Safety of the Ministry of Education, Institute of Nutrition, School of Public Health, NHC Specialty Laboratory of Food Safety Risk Assessment and Standard Development, Fudan University, Shanghai, China
6 shared publicationsBo Chen
Key Lab of Public Health Safety of the Ministry of Education, Institute of Nutrition, School of Public Health, Fudan University, Shanghai 200032, China
5 shared publicationsJianheng Zheng
Healthy aging research center, Nutrilite nutrition and health institute, Shanghai, China
5 shared publications
Latest Publications
- Open Access
- 17 October 2026
- Published by Elsevier in Environment International
- Vol. 217, 110564
Sputum microplastic concentrations and their association with underweight in patients with chronic obstructive pulmonary disease: first human evidence combined with integrated network toxicology analysis
- 17 October 2026
- Published by Elsevier in Environment International
- Vol. 217, 110564
Open AccessSputum microplastic concentrations and their association with underweight in patients with chronic obstructive pulmonary disease: first human evidence combined with integrated network toxicology analysis
- Open Access
- 14 September 2026
- Published by Springer Nature in BMC Geriatrics
Association of cumulative metal exposure with multidimensional cognitive and systemic inflammatory profiles in older adults
- 14 September 2026
- Published by Springer Nature in BMC Geriatrics
Open AccessAssociation of cumulative metal exposure with multidimensional cognitive and systemic inflammatory profiles in older adults
- Open Access
Lactiplantibacillus plantarum PD01 supplementation reduces microplastics and microplastic-associated chemicals in humans: A randomized, double-blind, placebo-controlled trial
BACKGROUND: Plastic products improve daily convenience but release pollutants that threaten human health, and effective elimination strategies remain limited. METHODS: In a randomized, double-blind, placebo-controlled trial, we assessed whether Lactiplantibacillus plantarum PD01, previously isolated from a donor with high-microplastic (MP) excretion, accelerates MP elimination. Of 106 participants recruited, 96 were randomized to placebo or PD01. Fecal MPs and urinary phthalate metabolites were measured by pyrolysis-gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry at baseline, week 3, and week 6. Primary outcomes were changes in MP concentrations and phthalate metabolite levels, analyzed with linear mixed-effects models. RESULTS: PD01 significantly increased fecal excretion of polycarbonate (PC) and total MPs at week 3 (PC: estimated mean difference, 3.19; 95% confidence interval [CI], 0.98 to 5.40; interaction P =0.005; total MPs: 1.99; 95% CI, 0.78 to 3.21; interaction P =0.001) and week 6 (PC: 2.87; 95% CI, 0.66 to 5.08; interaction P =0.011; total MPs: 1.25; 95% CI, 0.04 to 2.47; interaction P =0.044). By week 6, urinary phthalate metabolites were significantly lower with PD01 than placebo (MnBP: -0.96; 95% CI, -1.73 to -0.18; interaction P =0.016; MEHHP: -0.91; 95% CI, -1.79 to -0.02; interaction P =0.046; MECPP: -1.06; 95% CI, -2.09 to -0.03; interaction P =0.045; ΣDEHP: -0.97; 95% CI, -1.84 to -0.09; interaction P =0.031). CONCLUSIONS: This trial provides a feasible, low-cost, gut-targeted strategy to accelerate pollutant clearance and represents the first clinical evidence that human plastic burden can be lowered without dietary or behavioral restrictions. (ClinicalTrials.gov: NCT07416214 .)
Open AccessLactiplantibacillus plantarum PD01 supplementation reduces microplastics and microplastic-associated chemicals in humans: A randomized, double-blind, placebo-controlled trial
BACKGROUND: Plastic products improve daily convenience but release pollutants that threaten human health, and effective elimination strategies remain limited. METHODS: In a randomized, double-blind, placebo-controlled trial, we assessed whether Lactiplantibacillus plantarum PD01, previously isolated from a donor with high-microplastic (MP) excretion, accelerates MP elimination. Of 106 participants recruited, 96 were randomized to placebo or PD01. Fecal MPs and urinary phthalate metabolites were measured by pyrolysis-gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry at baseline, week 3, and week 6. Primary outcomes were changes in MP concentrations and phthalate metabolite levels, analyzed with linear mixed-effects models. RESULTS: PD01 significantly increased fecal excretion of polycarbonate (PC) and total MPs at week 3 (PC: estimated mean difference, 3.19; 95% confidence interval [CI], 0.98 to 5.40; interaction P =0.005; total MPs: 1.99; 95% CI, 0.78 to 3.21; interaction P =0.001) and week 6 (PC: 2.87; 95% CI, 0.66 to 5.08; interaction P =0.011; total MPs: 1.25; 95% CI, 0.04 to 2.47; interaction P =0.044). By week 6, urinary phthalate metabolites were significantly lower with PD01 than placebo (MnBP: -0.96; 95% CI, -1.73 to -0.18; interaction P =0.016; MEHHP: -0.91; 95% CI, -1.79 to -0.02; interaction P =0.046; MECPP: -1.06; 95% CI, -2.09 to -0.03; interaction P =0.045; ΣDEHP: -0.97; 95% CI, -1.84 to -0.09; interaction P =0.031). CONCLUSIONS: This trial provides a feasible, low-cost, gut-targeted strategy to accelerate pollutant clearance and represents the first clinical evidence that human plastic burden can be lowered without dietary or behavioral restrictions. (ClinicalTrials.gov: NCT07416214 .)
- Open Access
- 4 August 2026
- Published by Springer Nature in npj Science of Food
Lactiplantibacillus plantarum PD01 from high excretion donor functions as a natural defense against microplastic toxicity
- 4 August 2026
- Published by Springer Nature in npj Science of Food
Open AccessLactiplantibacillus plantarum PD01 from high excretion donor functions as a natural defense against microplastic toxicity
- Open Access
- 3 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Composite polyphenols mitigate microplastic exposure-related immune disturbances: a two-phase population trial
Microplastics (MPs) are widespread, making it urgent to elucidate their toxicity and identify intervention strategies. Here, we designed a two-phase population trial, comprising a baseline pilot population (n = 151) and a 28-day randomized, double-blind, placebo-controlled trial (n = 98). Primary outcomes include fecal MP concentration and blood parameters (complete blood count, glycemic and lipid, and cytokines), with exploratory outcomes comprising fecal metagenomics and plasma metabolomics. The median MP concentration in 151 participants' fecal samples is 158.28 μg/g dry weight, correlating with levels of 7 inflammatory indexes, 4 cytokines, and 2 lipid indicators. Composite polyphenols (CP) significantly reduced plasma levels of IL-1β (P = 0.045, effect sizes = -0.463), IL-6 (P = 0.023, effect sizes = -0.576) and IL-8 (P = 0.022, effect sizes = -0.529). 507 differentially expressed microbiotas (DEMs; P < 0.05) and 144 significantly different metabolites (SDMs; P-FDR < 0.25, VIP ≥ 1) are observed between the high and low MP exposure groups; 108 DEMs and 85 SDMs are identified following CP intervention. Notably, CP could mitigate the pro-inflammatory effects of high MP exposure by modulating gut microbiota and up-regulating glycerophospholipid metabolism and arginine biosynthesis. The gut bacteria Staphylococcus and the plasma metabolite PC (22:5/0:0) are identified as potential mediators in this protective effect. Trial registration: ClinicalTrials.gov: NCT06437119.
- 3 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessComposite polyphenols mitigate microplastic exposure-related immune disturbances: a two-phase population trial
Microplastics (MPs) are widespread, making it urgent to elucidate their toxicity and identify intervention strategies. Here, we designed a two-phase population trial, comprising a baseline pilot population (n = 151) and a 28-day randomized, double-blind, placebo-controlled trial (n = 98). Primary outcomes include fecal MP concentration and blood parameters (complete blood count, glycemic and lipid, and cytokines), with exploratory outcomes comprising fecal metagenomics and plasma metabolomics. The median MP concentration in 151 participants' fecal samples is 158.28 μg/g dry weight, correlating with levels of 7 inflammatory indexes, 4 cytokines, and 2 lipid indicators. Composite polyphenols (CP) significantly reduced plasma levels of IL-1β (P = 0.045, effect sizes = -0.463), IL-6 (P = 0.023, effect sizes = -0.576) and IL-8 (P = 0.022, effect sizes = -0.529). 507 differentially expressed microbiotas (DEMs; P < 0.05) and 144 significantly different metabolites (SDMs; P-FDR < 0.25, VIP ≥ 1) are observed between the high and low MP exposure groups; 108 DEMs and 85 SDMs are identified following CP intervention. Notably, CP could mitigate the pro-inflammatory effects of high MP exposure by modulating gut microbiota and up-regulating glycerophospholipid metabolism and arginine biosynthesis. The gut bacteria Staphylococcus and the plasma metabolite PC (22:5/0:0) are identified as potential mediators in this protective effect. Trial registration: ClinicalTrials.gov: NCT06437119.
- Open Access
- 18 February 2026
- Published by Elsevier in EBioMedicine
- Vol. 125
Microplastic-associated gut microbial profile and antibiotic resistance in preschool children: a multicentre cross-sectional study in China
- 18 February 2026
- Published by Elsevier in EBioMedicine
- Vol. 125
Open AccessMicroplastic-associated gut microbial profile and antibiotic resistance in preschool children: a multicentre cross-sectional study in China
- Open Access
- 17 April 2025
- Published by Elsevier in Environment International
- Vol. 199, 109485
Microplastics exposed by respiratory tract and exacerbation of community-acquired pneumonia: The potential influences of respiratory microbiota and inflammatory factors
- 17 April 2025
- Published by Elsevier in Environment International
- Vol. 199, 109485
Open AccessMicroplastics exposed by respiratory tract and exacerbation of community-acquired pneumonia: The potential influences of respiratory microbiota and inflammatory factors
- Open Access
- 1 July 2024
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 281, 116649
Phthalate exposure and markers of biological aging: The mediating role of inflammation and moderating role of dietary nutrient intake
- 1 July 2024
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 281, 116649
Open AccessPhthalate exposure and markers of biological aging: The mediating role of inflammation and moderating role of dietary nutrient intake
- Open Access
- 1 June 2024
- Published by Springer Nature in Nutrition & Diabetes
- Vol. 14 (1) , 1-10
Relationships between minerals’ intake and blood homocysteine levels based on three machine learning methods: a large cross-sectional study
Background: Blood homocysteine (Hcy) level has become a sensitive indicator in predicting the development of cardiovascular disease. Studies have shown an association between individual mineral intake and blood Hcy levels. The effect of mixed minerals’ intake on blood Hcy levels is unknown. Methods: Data were obtained from the baseline survey data of the Shanghai Suburban Adult Cohort and Biobank(SSACB) in 2016. A total of 38273 participants aged 20–74 years met our inclusion and exclusion criteria. Food frequency questionnaire (FFQ) was used to calculate the intake of 10 minerals (calcium, potassium, magnesium, sodium, iron, zinc, selenium, phosphorus, copper and manganese). Measuring the concentration of Hcy in the morning fasting blood sample. Traditional regression models were used to assess the relationship between individual minerals’ intake and blood Hcy levels. Three machine learning models (WQS, Qg-comp, and BKMR) were used to the relationship between mixed minerals’ intake and blood Hcy levels, distinguishing the individual effects of each mineral and determining their respective weights in the joint effect. Results: Traditional regression model showed that higher intake of calcium, phosphorus, potassium, magnesium, iron, zinc, copper, and manganese was associated with lower blood Hcy levels. Both Qg-comp and BKMR results consistently indicate that higher intake of mixed minerals is associated with lower blood Hcy levels. Calcium exhibits the highest weight in the joint effect in the WQS model. In Qg-comp, iron has the highest positive weight, while manganese has the highest negative weight. The BKMR results of the subsample after 10,000 iterations showed that except for sodium, all nine minerals had the high weights in the joint effect on the effect of blood Hcy levels. Conclusion: Overall, higher mixed mineral’s intake was associated with lower blood Hcy levels, and each mineral contributed differently to the joint effect. Future studies are available to further explore the mechanisms underlying this association, and the potential impact of mixed minerals’ intake on other health indicators needs to be further investigated. These efforts will help provide additional insights to deepen our understanding of mixed minerals and their potential role in health maintenance.
- 1 June 2024
- Published by Springer Nature in Nutrition & Diabetes
- Vol. 14 (1) , 1-10
Open AccessRelationships between minerals’ intake and blood homocysteine levels based on three machine learning methods: a large cross-sectional study
Background: Blood homocysteine (Hcy) level has become a sensitive indicator in predicting the development of cardiovascular disease. Studies have shown an association between individual mineral intake and blood Hcy levels. The effect of mixed minerals’ intake on blood Hcy levels is unknown. Methods: Data were obtained from the baseline survey data of the Shanghai Suburban Adult Cohort and Biobank(SSACB) in 2016. A total of 38273 participants aged 20–74 years met our inclusion and exclusion criteria. Food frequency questionnaire (FFQ) was used to calculate the intake of 10 minerals (calcium, potassium, magnesium, sodium, iron, zinc, selenium, phosphorus, copper and manganese). Measuring the concentration of Hcy in the morning fasting blood sample. Traditional regression models were used to assess the relationship between individual minerals’ intake and blood Hcy levels. Three machine learning models (WQS, Qg-comp, and BKMR) were used to the relationship between mixed minerals’ intake and blood Hcy levels, distinguishing the individual effects of each mineral and determining their respective weights in the joint effect. Results: Traditional regression model showed that higher intake of calcium, phosphorus, potassium, magnesium, iron, zinc, copper, and manganese was associated with lower blood Hcy levels. Both Qg-comp and BKMR results consistently indicate that higher intake of mixed minerals is associated with lower blood Hcy levels. Calcium exhibits the highest weight in the joint effect in the WQS model. In Qg-comp, iron has the highest positive weight, while manganese has the highest negative weight. The BKMR results of the subsample after 10,000 iterations showed that except for sodium, all nine minerals had the high weights in the joint effect on the effect of blood Hcy levels. Conclusion: Overall, higher mixed mineral’s intake was associated with lower blood Hcy levels, and each mineral contributed differently to the joint effect. Future studies are available to further explore the mechanisms underlying this association, and the potential impact of mixed minerals’ intake on other health indicators needs to be further investigated. These efforts will help provide additional insights to deepen our understanding of mixed minerals and their potential role in health maintenance.